Northwestern Mutual Wealth Management
RANI icon

Northwestern Mutual Wealth Management’s Rani Therapeutics RANI Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,000
Closed -$18K – 3291
2021
Q3 		$18K Buy
+1,000
New +$17.3K ﹤0.01% 2263

Other funds holding RANI

NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ASGS
Alpha Square Group S New York $103M AUM 63.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Northwestern Mutual Wealth Management's RANI Position: Q4 2021 in Review

Northwestern Mutual Wealth Management sold out of Rani Therapeutics (RANI) in Q4 2021, closing a stake of 1,000 shares — an estimated $18K sold.

Northwestern Mutual Wealth Management first reported a position in RANI in Q3 2021 and held it in 1 quarter. The position peaked at $18K in Q3 2021. 22 funds tracked by Wall St. Rank hold RANI as of Q4 2021.

  • Northwestern Mutual Wealth Management reported no remaining Rani Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 1,000 Rani Therapeutics shares in Q4 2021, an estimated $18K.
  • Northwestern Mutual Wealth Management first reported a position in Rani Therapeutics in Q3 2021 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Rani Therapeutics position peaked at $18K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Rani Therapeutics as of Q4 2021.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2021, filed 3 Feb 2022.